Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin's lymphoma. Results of the HDR-ALLO study - a prospective clinical trial by the Grupo Español de Linfomas/ Trasplante de Médula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

  1. Sureda, A.
  2. Canals, C.
  3. Arranz, R.
  4. Caballero, D.
  5. Ribera, J.M.
  6. Brune, M.
  7. Passweg, J.
  8. Martino, R.
  9. Valcárcel, D.
  10. Besalduch, J.
  11. Duarte, R.
  12. León, A.
  13. Pascual, M.J.
  14. García-Noblejas, A.
  15. Corral, L.L.
  16. Xicoy, B.
  17. Sierra, J.
  18. Schmitz, N.
Revue:
Haematologica

ISSN: 0390-6078,  1592-8721

Année de publication: 2012

Volumen: 97

Número: 2

Pages: 310-317

Type: Article

DOI: 10.3324/HAEMATOL.2011.045757 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus